WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing

This publication has 51 references indexed in Scilit:

• Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms
  Journal of Biological Chemistry, 2010
• Neutralization of Vascular Endothelial Growth Factor Antiangiogenic Isoforms Is More Effective Than Treatment with Proangiogenic Isoforms in Stimulating Vascular Development and Follicle Progression in the Perinatal Rat Ovary1
  Biology of Reproduction, 2009
• VEGF121b, a new member of the VEGFxxxb family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo
  British Journal of Cancer, 2009
• Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones
  Genes & Development, 2009
• Molecular Diversity of VEGF-A as a Regulator of Its Biological Activity
  Microcirculation, 2009
• VEGF-A splicing: the key to anti-angiogenic therapeutics?
  Nature Reviews Cancer, 2008
• Ras Promotes Growth by Alternative Splicing-Mediated Inactivation of the KLF6 Tumor Suppressor in Hepatocellular Carcinoma
  Gastroenterology, 2008
• The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice
  British Journal of Cancer, 2008
• VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
  British Journal of Cancer, 2008
• Utilization of host SR protein kinases and RNA-splicing machinery during viral replication
  Proceedings of the National Academy of Sciences, 2006